- 3.10.2026
- Press Releases
VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive Year
Amber Capone, co-founder and CEO of VETS, has been named to Inc.’s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing research, policy reform, and expanded access to psychedelic-assisted therapies for veterans.
- 3.9.2026
- News
Honolulu Civil Beat: Hawaiʻi Should Expand Legal Access To Psychedelics
In testimony before the Hawaiʻi State Legislature, a veteran spouse and VETS Foundational Healing Grant recipient highlights her family’s experience traveling abroad for psychedelic-assisted therapy and calls for policies that expand safe, regulated access for veterans.
- 3.3.2026
- News
The New York Times: How the Psychedelic Drug Ibogaine Changed Me Forever
In a recent New York Times article, Robert Draper recounts his ibogaine experience and notes that VETS helps veterans access treatment at vetted facilities abroad, including Ambio. Through its Foundational Healing Grant Program, VETS provides funding and comprehensive support before, during, and after treatment.
- 2.19.2026
- News
Deseret News: Could a Legislative Bill Hold the Key to Treating Veterans Battling PTSD?
VETS, alongside Utah veterans, advocates for legislation that would enable clinical trials to study the efficacy of psychedelic-assisted therapy among veterans with PTSD in the Beehive State.
- 2.19.2026
- Blog
From Combat to Clarity: My Journey to Peace
In this moving testimony, Air Force veteran Kevin Kloeppel shares how years of high-stakes Special Operations missions left him fighting an internal war, and how a VETS Foundational Healing Grant helped him rediscover connection, clarity, and a lasting sense of peace beyond the uniform.
- 2.18.2026
- Blog
Access Isn’t a Buzzword: What Veterans Actually Need to Reach Psychedelic-Assisted Therapy
A powerful reflection on what “access” to psychedelic-assisted therapy truly means for veterans and their families—and why research, advocacy, and wrap-around support are essential to making safe, regulated care a real option, not just a talking point.
Marcus Capone & Jon Shenk - 'In Waves and War' & Healing Trauma with Psychedelics
VETS Co-founder and Board Chair, Marcus Capone and 'In Waves and War' Director Jon Shenk join Michael Kosta on the Daily Show to talk veteran mental health and the healing potential of psychedelic-assisted therapy.
From Breakthrough to Movement: How Veterans Sparked a Psychedelic Research Revolution
From the first state-funded psilocybin study to multi-million dollar legislative wins, VETS has helped turn hope into policy. In this powerful piece, Logan Davidson details how veterans became the trusted messengers behind a wave of psychedelic research funding—and why bipartisan, evidence-backed legislation is now one of the most promising frontiers in mental health.
- 1.30.2026
- Stanford Research
Men’s Journal: Study — New Psychedelic Drug Combo Improves PTSD
Reports on the mystical-experience paper, noting PTSD symptom reductions in 30 male veterans after magnesium–ibogaine treatment. It presents the findings as preliminary support for larger PTSD trials.
- 1.26.2026
- Blog
Why VETS Funds Both Treatment Access and Research: The “Now + Next” Mindset
VETS’ “Now + Next” model connects urgent access to psychedelic-assisted therapy with long-term systems change through research and policy. This approach ensures veterans get the support they need today—while building a future where healing is accessible, credible, and sustained.